These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 25283275)
1. Generation of a Tlx1(CreER-Venus) knock-in mouse strain for the study of spleen development. Nakahara R; Kawai Y; Oda A; Nishimura M; Murakami A; Azuma T; Kaifu T; Goitsuka R Genesis; 2014 Nov; 52(11):916-23. PubMed ID: 25283275 [TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of tamoxifen-inducible Pax9-CreER knock-in mice using CrispR/Cas9. Feng J; Jing J; Sanchez-Lara PA; Bootwalla MS; Buckley J; Wu N; Yan Y; Chai Y Genesis; 2016 Sep; 54(9):490-6. PubMed ID: 27381449 [TBL] [Abstract][Full Text] [Related]
3. Niche-induced extramedullary hematopoiesis in the spleen is regulated by the transcription factor Tlx1. Oda A; Tezuka T; Ueno Y; Hosoda S; Amemiya Y; Notsu C; Kasahara T; Nishiyama C; Goitsuka R Sci Rep; 2018 May; 8(1):8308. PubMed ID: 29844356 [TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of a tamoxifen inducible Msx1(CreERT2) knock-in allele. Lallemand Y; Moreau J; Cloment CS; Vives FL; Robert B Genesis; 2013 Feb; 51(2):110-9. PubMed ID: 23090744 [TBL] [Abstract][Full Text] [Related]
5. Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system. Martinez-Corral I; Stanczuk L; Frye M; Ulvmar MH; Diéguez-Hurtado R; Olmeda D; Makinen T; Ortega S Angiogenesis; 2016 Jul; 19(3):433-45. PubMed ID: 26993803 [TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of a tamoxifen-inducible Eomes(CreER) mouse line. Pimeisl IM; Tanriver Y; Daza RA; Vauti F; Hevner RF; Arnold HH; Arnold SJ Genesis; 2013 Oct; 51(10):725-33. PubMed ID: 23897762 [TBL] [Abstract][Full Text] [Related]
8. The Sox17CreERT2 knock-in mouse line displays spatiotemporal activation of Cre recombinase in distinct Sox17 lineage progenitors. Engert S; Burtscher I; Kalali B; Gerhard M; Lickert H Genesis; 2013 Nov; 51(11):793-802. PubMed ID: 24038996 [TBL] [Abstract][Full Text] [Related]
9. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector. Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440 [TBL] [Abstract][Full Text] [Related]
10. CreER(T2) expression from within the c-Kit gene locus allows efficient inducible gene targeting in and ablation of mast cells. Heger K; Seidler B; Vahl JC; Schwartz C; Kober M; Klein S; Voehringer D; Saur D; Schmidt-Supprian M Eur J Immunol; 2014 Jan; 44(1):296-306. PubMed ID: 24127407 [TBL] [Abstract][Full Text] [Related]
11. Genetic inducible fate mapping in adult mice using tamoxifen-dependent Cre recombinases. Feil S; Krauss J; Thunemann M; Feil R Methods Mol Biol; 2014; 1194():113-39. PubMed ID: 25064100 [TBL] [Abstract][Full Text] [Related]
12. Transcription factor Tlx1 marks a subset of lymphoid tissue organizer-like mesenchymal progenitor cells in the neonatal spleen. Ueno Y; Fujisaki K; Hosoda S; Amemiya Y; Okazaki S; Notsu C; Nishiyama C; Mabuchi Y; Matsuzaki Y; Oda A; Goitsuka R Sci Rep; 2019 Dec; 9(1):20408. PubMed ID: 31892733 [TBL] [Abstract][Full Text] [Related]